tiprankstipranks
Sigyn Therapeutics (SIGY)
OTHER OTC:SIGY
US Market
SIGY
Sigyn Therapeutics
RESEARCH TOOLSreports

Sigyn Therapeutics (SIGY) Income Statement

13 Followers

Sigyn Therapeutics Income Statement

Last quarter (Q3 2025), Sigyn Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sigyn Therapeutics's net income was $-578.50K. See Sigyn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -8.86K$ -10.45K-$ -11.30K
Operating Expenses
$ 2.52M$ 2.46M$ 2.15M$ 2.01M$ 916.43K
Depreciation and Amortization
$ 817.59K$ 8.86K$ 10.45K$ 19.15K$ 11.30K
EBITDA
$ -2.52M$ -2.45M$ -2.14M$ -2.53M$ -905.13K
Operating Income
$ -2.52M$ -2.46M$ -2.15M$ -2.01M$ -916.43K
Other Income/Expenses
$ -820.97K$ -1.69M$ -782.55K$ -996.40K$ -343.16K
Pretax Income
$ -3.34M$ -4.15M$ -2.93M$ -3.00M$ -1.26M
Net Income
$ -3.34M$ -4.15M$ -3.71M$ -3.40M$ -1.60M
Per Share Metrics
Basic EPS
$ -2.51$ -3.77$ -3.97$ -0.09$ -0.22
Diluted EPS
$ -2.51$ -3.77$ -3.97$ -0.09$ -0.22
Weighted Average Shares Outstanding
 1.33M 1.10M 934.00K 36.40M 7.35M
Weighted Average Shares Outstanding (Diluted)
 1.33M 1.10M 934.00K 36.40M 7.35M
Currency in USD

Sigyn Therapeutics Earnings and Revenue History